South Texas Accelerated Research Therapeutics (START) Mountain Region

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Neuroendocrine tumours1 trial
• Pancreatic cancer1 trial
• Prostate cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 12 trials
• Phase 1/21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• MacroGenics1 trial
• Monte Rosa Therapeutics, Inc1 trial
• NiKang Therapeutics, Inc.1 trial

Running trials

• Recruiting

  A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  NCT07029399· Phase 1· NiKang Therapeutics, Inc.· Source

  Contact: HOPE Team

• Recruiting

  A Study of MGC028 in Participants With Advanced Solid Tumors

  NCT06723236· Phase 1· MacroGenics· Source

  Contact: Global Trial Manager

• Active, not recruiting

  Study of Oral MRT-2359 in Selected Cancer Patients

  NCT05546268· Phase 1/2· Monte Rosa Therapeutics, Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting